Japan Implantable Devices in Coronary Artery Disease (JID-CAD) study design.
BACKGROUND
There is little information regarding appropriate therapies for coronary artery disease (CAD) patients with implantable devices - such as implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRT-Ds) and cardiac resynchronization therapy pacemaker (CRT-P) devices - in Japan. To address this lack of information, we have launched the Japan Implantable Devices in Coronary Artery Disease (JID-CAD) study.


METHODS
This study has been designed as a prospective, multicenter, non-randomized and observational investigation. All patients will be followed up every six months over a two-year period. The primary endpoint will be the administration of appropriate device therapy. Secondary endpoints include administration of inappropriate therapy, death, hospitalization, or cardiovascular events.


CONCLUSIONS
In this report, we discuss the current clinical situation of appropriate therapy, and how it is influenced by catheter ablation and revascularization therapy in patients with CAD.
Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan.
Akihiko
A
Shimizu
Jichi Medical University Saitama Medical Center, Saitama, Japan.
Takeshi
T
Mitsuhashi
Nippon Medical School, Tokyo, Japan.
Takashi
T
Nitta
Tachikawa Hospital, Tokyo, Japan.
Hideo
H
Mitamura
Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
Takashi
T
Kurita
University of Occupational and Environmental Health, Fukuoka, Japan.
Haruhiko
H
Abe
Juntendo University Urayasu Hospital, Chiba, Japan.
Yuji
Y
Nakazato
Nihon University School of Medicine, Tokyo, Japan.
Naokata
N
Sumitomo
Kurashiki Central Hospital, Okayama, Japan.
Kazushige
K
Kadota
Yokohama City University Medical Center, Kanagawa, Japan.
Kazuo
K
Kimura
Hirosaki University Graduate School of Medicine, Aomori, Japan.
Ken
K
Okumura
Cardiac implantable devices; Coronary artery disease; Implantable cardioverter-defibrillator; Japan